The Christie NHS Foundation Trust

What The Christie NHS Foundation Trust does

The Christie NHS Foundation Trust is an NHS public benefit corporation operating Europe's largest single-site cancer centre from its Withington, Manchester headquarters, with a hub-and-spoke network of 15+ satellite treatment centres across Greater Manchester, Cheshire, Derbyshire, and North Staffordshire. Founded as a hospital in 1892 and established as a Foundation Trust in 2003, it employs between 1,001 and 5,000 staff and is the first UK hospital accredited as a comprehensive cancer centre and the first specialist hospital rated Outstanding twice by the CQC. Its core clinical offering covers radiotherapy (including MR-Linac, stereotactic, IMRT, VMAT), systemic anti-cancer therapy (chemotherapy, immunotherapy, CAR-T), proton beam therapy (the only UK high-energy proton beam facility), and specialized surgical oncology, supported by departments for colorectal and peritoneal oncology, neuro-oncology, lymphoma, and haematology.

Revenue is generated primarily through NHS England commissioning contracts for publicly funded cancer care, supplemented by private patient services delivered through an HCA Healthcare partnership, research funding from Cancer Research UK (currently over £17m/year to the co-located Manchester Institute), and charitable income via The Christie Charity subsidiary. The trust also pursues international advisory work through partnerships in Egypt, Kenya, Kazakhstan, Malta, Jordan, Australia, and Ireland, and has invested in digital transformation (Netcall Liberty Spark) that has retired 30% of forms and reduced manual data entry by up to 50% across 70+ mapped care processes. Patient-facing channels include the MyChristie portal, Attend Anywhere video clinics, The Christie at Home service, and a Bloods Closer to Home phlebotomy network.

Name

The Christie NHS Foundation Trust

Legal name

The Christie NHS Foundation Trust

Website

https://christie.nhs.uk

Company type

Private

Founded year

1892

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

The Christie NHS Foundation Trust operates Europe's largest single-site cancer centre in Manchester, delivering radiotherapy, chemotherapy, proton beam therapy, and surgery through 15+ sites across Greater Manchester and Cheshire, serving NHS patients plus private and international partners.

Ownership category

akta.pro rank

Product category

Specialty Cancer Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), Offices of Physicians (62111)

SIC

Services-Hospitals (8060), Services-Health Services (8000)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Radiation Oncology (HLAKAFAC), Medical Oncology (HLAKAFAB)

Keywords

• Cancer treatment services
• Radiotherapy services
• Oncology care
• Proton beam therapy
• Cancer research

Headquarters

HQ city

Manchester

HQ country

United Kingdom

HQ region

Europe

Offices12 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Others

Revenue model

1. NHS Publicly Funded Healthcare: The Christie operates as an NHS Foundation Trust, providing publicly funded cancer care services commissioned by NHS England and local clinical commissioning groups. Revenue is derived from NHS service contracts based on activity and population needs.
2. Private Patient Services: The trust offers private care options through a partnership with HCA Healthcare, providing self-pay and insured patients with access to Christie specialists outside NHS pathways.
3. Research Funding and Clinical Trials: The trust receives research funding from Cancer Research UK and other grant bodies. Additional funding of £6m per year increase announced for Manchester Institute, with two clinician scientist positions in partnership with The Christie.

Go-to-market motion1 record

Distribution channels7 records

Marketing channels6 records

Core offering

The Christie NHS Foundation Trust is a specialist comprehensive cancer centre that diagnoses and treats cancer through radiotherapy (including MR-Linac, stereotactic, IMRT, VMAT), systemic anti-cancer therapy (chemotherapy, immunotherapy), proton beam therapy, surgery (including CAR-T cell therapy and brachytherapy), and supportive care. Services are delivered at the main Withington site in Manchester and through a network of 15+ satellite treatment centres across Greater Manchester and Cheshire. The Trust also runs clinical trials, research programmes in partnership with Cancer Research UK, and offers private patient services through HCA Healthcare.

Product overview

The Christie NHS Foundation Trust is a specialized cancer hospital providing integrated cancer care services. The Trust operates as a single unified hospital with distributed satellite sites, offering a comprehensive portfolio of treatment services including radiotherapy, systemic anti-cancer therapy (SACT), proton beam therapy, surgery, CAR-T cell therapy, and brachytherapy. These core clinical services are supported by specialized departments including the Colorectal and Peritoneal Oncology Centre, Neuro-oncology, Lymphoma, and Haematology. Patient-facing digital services include the MyChristie patient portal with health monitoring capabilities, The Christie at Home for remote treatment delivery, and the Bloods Closer to Home phlebotomy service. The Trust maintains additional support services through Christie Medical Physics and Engineering and The Christie Pharmacy.

Differentiator

Problem solved

Functional benefit

Brands

• MyChristie: Patient portal allowing patients to access appointments, test results, and manage their care.
• The Christie Charity

Products and services

• Radiotherapy
• Systemic Anti-Cancer Therapy (SACT)
• Proton Beam Therapy
• Surgery
• CAR-T Cell Therapy
• Brachytherapy
• Colorectal and Peritoneal Oncology Centre (CPOC)
• Neuro-oncology Service
• Lymphoma Service
• Haematology and Transplant Unit
• MyChristie Patient Portal
• The Christie at Home
• Bloods Closer to Home
• The Christie at Macclesfield

Quantifiable outcome

• 46,000 patient appointments and visits per year at Macclesfield site alone
• +4 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature2 records

Partnerships

17 partnerships are on record, tiered core and minor.

• Cancer Research UK Manchester InstitutecoreStrategic or Co-development Partner · 17 June 2026Cancer Research UK announced increased annual investment from £11m to more than £17m, representing £6m additional per year. The funding supports recruitment of up to eight senior researchers and up to 100 new research positions focused on immunology, data science, and AI. Two new clinician scientist positions established in partnership with The Christie hospital, with directly connected facilities enabling rapid transfer of patient samples to research labs.
• Poolbeg PharmaminorStrategic or Co-development Partner · 9 December 2025Poolbeg Pharma announced that its POLB 001 TOPICAL trial will be part of the RISE research programme focused on reducing cytokine release syndrome in cancer immunotherapy. Johnson & Johnson is providing a bispecific antibody for the programme.
• Johnson & JohnsonminorStrategic or Co-development Partner · 9 December 2025Johnson & Johnson is providing a bispecific antibody for the RISE research programme focused on reducing cytokine release syndrome in cancer immunotherapy. The programme aims to improve safety of advanced cancer therapies.
• NetcallcoreTechnology or Integration · 6 November 2025The Christie completed a four-month digital transformation project using Netcall's Liberty Spark to map and analyze over 70 care processes across nine patient pathways. The initiative achieved efficiency gains and is being considered as a model for other NHS trusts.
• HCA HealthcarecoreChannel Partner/ Reseller/ DistributorPartnership for private care services. HCA Healthcare operates The Christie Private Care facility, providing self-pay and insured patients access to Christie cancer specialists in private healthcare settings.
• Health Innovation ManchestercoreStrategic or Co-development PartnerPartnership focused on health innovation initiatives in the Greater Manchester region, supporting innovation and improvement in cancer care delivery.
• Manchester Cancer Research Centre (MCRC)coreStrategic or Co-development PartnerPartnership with Manchester Cancer Research Centre for collaborative cancer research activities, combining clinical expertise with research capabilities.
• Greater Manchester Cancer VanguardminorStrategic or Co-development PartnerCollaboration through the Greater Manchester Cancer Vanguard initiative to advance cancer care across the region.
• Cork University HospitalminorStrategic or Co-development PartnerInternational partnership supporting cancer care development at Cork University Hospital.
• King Hussein Cancer Centre (Jordan)minorStrategic or Co-development PartnerPartnership with Colorectal and Peritoneal Oncology Centre (CPOC) and The King Hussein Cancer Centre for international collaboration in cancer care.
• Peter MacCallum Cancer Centre (Australia)minorStrategic or Co-development PartnerInternational collaboration with The Peter MacCallum Cancer Centre in Australia to strengthen cancer research and treatment capabilities.
• Egypt Healthcare AuthorityminorStrategic or Co-development PartnerPartnership working with Egypt Healthcare Authority to improve cancer outcomes through Christie expertise and advisory services.
• African Medical Centre of ExcellenceminorStrategic or Co-development PartnerSupporting the African Medical Centre of Excellence project to develop cancer care capabilities in Africa through Christie advisory and expertise.
• MATER DEI Hospital (Malta)minorStrategic or Co-development PartnerProviding advisory services to MATER DEI Hospital in Malta for oncology service development.
• Kenyan Healthcare PartnersminorStrategic or Co-development PartnerWorking with Kenyan partners to improve cancer outcomes through training, advisory, and support services.
• Kazakhstan Medical Training PartnersminorStrategic or Co-development PartnerChristie helps train doctors in Kazakhstan to improve cancer care capabilities in the region.
• King's International ConsortiumminorStrategic or Co-development PartnerMember of King's International Consortium for global health collaboration and cancer care improvement.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• The Royal Marsden NHS Foundation Trust: UK's other flagship specialist cancer hospital, also NHS Foundation Trust, providing comprehensive oncology services including radiotherapy, SACT, surgery, and clinical trials; the closest direct comparator to The Christie in scale, scope, and academic standing.
• The Clatterbridge Cancer Centre NHS Foundation Trust: Specialist NHS cancer centre covering Merseyside and Cheshire with multiple radiotherapy and chemotherapy sites; directly comparable operating model and satellite network structure to The Christie.

Broad incumbents

• University College London Hospitals NHS Foundation Trust: Major London academic NHS trust running a substantial haemato-oncology and cancer service alongside general acute specialties; overlapping tertiary cancer referrals and research partnerships.
• Guy's and St Thomas' NHS Foundation Trust: Large London NHS Foundation Trust with comprehensive cancer services including radiotherapy, SACT and clinical trials; comparable NHS academic hospital structure with research leadership.
• MD Anderson Cancer Center: World-leading US comprehensive cancer centre operating at far larger scale; benchmarks research intensity, proton beam therapy and CAR-T capability that The Christie aspires to scale.
• Memorial Sloan Kettering Cancer Center: US comprehensive cancer centre with deep research portfolio and clinical trial leadership; comparable in offering the full cancer care continuum from a single specialist footprint.
• Imperial College Healthcare NHS Trust: London-based academic NHS trust with significant oncology services and translational research; comparable NHS academic provider model though not exclusively cancer-focused.

Emerging players

• GenesisCare: Private specialist provider of radiotherapy and oncology services across the UK and Australia; competes for private and insured patients and overlaps with The Christie's private offering.

Others

• HCA Healthcare UK: Christie's private care partner delivering self-pay and insured oncology services at The Christie Private Care; relevant as both distribution partner and indirect private competitor.

Regional players

• Peter MacCallum Cancer Centre: Australia's only public specialist cancer hospital, with similar comprehensive cancer centre model and active research partnership with The Christie; comparable peer despite operating in a different geography.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/thechristienhs
• YouTubeyoutube.com/channel/UCgl_gIdOJkj0Nqe9pWrzQtw
• Facebookfacebook.com/thechristienhs
• LinkedInlinkedin.com/company/the-christie-nhs-foundation-trust

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Christie NHS Foundation Trust